CA2385893A1 - Sequences caracteristiques du cancer de la vessie - Google Patents

Sequences caracteristiques du cancer de la vessie Download PDF

Info

Publication number
CA2385893A1
CA2385893A1 CA002385893A CA2385893A CA2385893A1 CA 2385893 A1 CA2385893 A1 CA 2385893A1 CA 002385893 A CA002385893 A CA 002385893A CA 2385893 A CA2385893 A CA 2385893A CA 2385893 A1 CA2385893 A1 CA 2385893A1
Authority
CA
Canada
Prior art keywords
bladder cancer
sequences
gene
patient
tcc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002385893A
Other languages
English (en)
Inventor
Elena Feinstein
Orna Mor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quark Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2385893A1 publication Critical patent/CA2385893A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention porte: sur un procédé de diagnostic du cancer de la vessie chez un patient par analyse d'un prélèvement de tissu pour y rechercher au moins un gène exprimé dont la présence est révélatrice du cancer de la vessie; sur une séquence de polynucléotide dont la présence est révélatrice du cancer de la vessie; sur un marqueur de cancer de la vessie; sur des procédés de diagnostic du cancer de la vessie par criblage pour détecter la présence d'au moins un gène exprimé dont la présence est révélatrice du cancer de la vessie; et sur des procédés de traitement et régulation des pathologies associées au cancer de la vessie par administration à un patient de doses à efficacité thérapeutique d'un ribozyme, d'un oligonucléotide antisens, ou d'un agoniste, agissant contre les séquences d'acides nucléiques de la présente invention.
CA002385893A 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie Abandoned CA2385893A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15615399P 1999-09-27 1999-09-27
US60/156,153 1999-09-27
PCT/US2000/041005 WO2001022864A2 (fr) 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie

Publications (1)

Publication Number Publication Date
CA2385893A1 true CA2385893A1 (fr) 2001-04-05

Family

ID=22558336

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002385893A Abandoned CA2385893A1 (fr) 1999-09-27 2000-09-27 Sequences caracteristiques du cancer de la vessie

Country Status (5)

Country Link
EP (1) EP1248855A4 (fr)
AU (1) AU1492601A (fr)
CA (1) CA2385893A1 (fr)
IL (1) IL148798A0 (fr)
WO (1) WO2001022864A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998232B1 (en) 1999-09-27 2006-02-14 Quark Biotech, Inc. Methods of diagnosing bladder cancer
WO2002086084A2 (fr) * 2001-04-04 2002-10-31 Quark Biotech, Inc. Caracteristiques sequentielles d'un cancer de la vessie
KR20220012993A (ko) 2004-07-23 2022-02-04 퍼시픽 에지 리미티드 방광암 검출용 소변 표지
CN101175862A (zh) * 2005-02-10 2008-05-07 肿瘤疗法科学股份有限公司 诊断膀胱癌的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856136A (en) * 1996-07-03 1999-01-05 Incyte Pharmaceuticals, Inc. Human stem cell antigens
DE19818619A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Tumor

Also Published As

Publication number Publication date
WO2001022864A3 (fr) 2001-11-01
EP1248855A2 (fr) 2002-10-16
EP1248855A4 (fr) 2004-12-22
AU1492601A (en) 2001-04-30
WO2001022864A2 (fr) 2001-04-05
WO2001022864A9 (fr) 2002-12-12
IL148798A0 (en) 2002-09-12

Similar Documents

Publication Publication Date Title
US6998232B1 (en) Methods of diagnosing bladder cancer
CA1341576C (fr) Diagnostic du retinoblastome
AU2013337277B2 (en) Novel NTRK1 fusion molecules and uses thereof
US8133724B2 (en) Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
US20180171416A1 (en) Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
EP1009753B1 (fr) Genes regules au niveau de l'hypoxemie
JP2014525586A (ja) 大腸癌の処置および診断のための方法および組成物
JP2012504426A (ja) Ｇｏｌｐｈ３を使用する癌の診断、予後およびモニタリングのための組成物、キットおよび方法
JPH11505125A (ja) 血管拡張性運動失調症遺伝子及びそのゲノム構成
CA2341705A1 (fr) Sequences caracteristiques de la transcription genique regulee par l'hypoxemie
CA2410949A1 (fr) Nouveau genes cibles pour les maladies du coeur
JP2004505631A (ja) リシルオキシダーゼ遺伝子ファミリーの新規メンバー
US5756676A (en) Mammalian protein associated with uncontrolled cell division
CA2385893A1 (fr) Sequences caracteristiques du cancer de la vessie
US20030032769A1 (en) Second mammalian tankyrase
JP2006524492A (ja) 血管形成に関連する核酸分子を同定するための方法
US20030008284A1 (en) Polynucleotides related to colon cancer
US20100136577A1 (en) Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
EP1370693B1 (fr) Gene du cancer amplifie wip1
WO2002086084A2 (fr) Caracteristiques sequentielles d'un cancer de la vessie
US7973156B2 (en) Hypoxia-regulated genes
US20050221326A1 (en) Oligonucleotides antibodies and kits including same for treating prostate cancer and determining predisposition thereto
US9079938B2 (en) ASPP2 splicing variant
CA2253002A1 (fr) Methode et marqueur pour l'identification de tumeurs premalignes et malignes, et intervention therapeutique
US20030099985A1 (en) Amplified gene involved in cancer

Legal Events

Date Code Title Description
FZDE Discontinued